Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0383820110700030251
Tuberculosis and Respiratory Diseases
2011 Volume.70 No. 3 p.251 ~ p.256
A Case of Prothionamide Induced Hepatitis on Patient with Multi-Drug Resistant Pulmonary Tuberculosis
Park Jun-Beom

Park Byung-Hoon
Son Ji-Young
Jung Ji-Ye
Kim Eun-Young
Lim Ju-Eun
Lee Sang-Hoon
Lee Sang-Kook
Kim Song-Yee
Jung Won-Jai
Lim Seung-Taek
Lee Kyung-Jong
Kang Young-Ae
Kim Young-Sam
Kim Se-Kyu
Chang Joon
Choi Jun-Jeong
Park Moo-Suk
Abstract
The prevalence of multi-drug resistant tuberculosis (MDR-TB), which is resistant to isoniazid and rifampin, has been increasing in Korea. And the side effects of 2nd line anti-tuberculosis medications, including drug-induced hepatitis, are well known. Although prothionamide (PTH) is one of the most useful anti-TB medications and although TB medication-induced acute hepatitis is a severe complication, there are only a few published case reports about prothionamide induced hepatitis. In this case report, a 22 year old male was diagnosed with pulmonary MDR-TB and was administered 2nd line anti-TB mediations, including PTH. Afterwards, he had a spiking fever and his liver enzymes were more than 5 times greater than the upper limit of the normal range. He was then diagnosed with drug-induced hepatitis by liver biopsy. His symptoms and liver enzyme elevation were improved after stopping PTH. Accordingly, we report this case of an association between PTH and acute hepatitis.
KEYWORD
Tuberculosis, Multidrug-Resistant, Hepatitis, Prothionamide
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø